Brevilin A was found to target the VEGF-IL6-STAT3 axis in colorectal cancer-hepatic stellate cells (CRC-HSCs) interactions, resulting in significant inhibition of colorectal liver metastasis and further cancer progression in vitro and in vivo [64]. This evidence concerns the gene STAT3 and cancer.